{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:31:29Z","timestamp":1786120289024,"version":"build-2736575974"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1097\/lgt.0b013e3182422c69","type":"journal-article","created":{"date-parts":[[2012,3,27]],"date-time":"2012-03-27T06:42:54Z","timestamp":1332830574000},"page":"256-262","source":"Crossref","is-referenced-by-count":13,"title":["The Immunoexpression of Heparanase 2 in Normal Epithelium, Intraepithelial, and Invasive Squamous Neoplasia of the Cervix"],"prefix":"10.1097","volume":"16","author":[{"given":"Renato Moretti","family":"Marques","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo Rubino","family":"Focchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Th\u00e9r\u00e8se Rachell","family":"Theodoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adauto","family":"Castelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Aparecida","family":"Pinhal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9rgio Mancini","family":"Nicolau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20210126","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1093\/annonc\/mdr015","article-title":". Worldwide burden of cervical cancer in 2008.","volume":"22","author":"Arbyn","year":"2011","journal-title":"Ann Oncol"},{"key":"R3-9-20210126","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1186\/1471-2407-10-553","article-title":"Expression pattern of matrix metalloproteinases in human gynecological cancer cell lines.","volume":"10","author":"Schropfer","year":"2010","journal-title":"BMC Cancer"},{"key":"R4-9-20210126","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.2174\/138161209787846676","article-title":"A fresh prospect of extracellular matrix hydrolytic enzymes and their substrates.","volume":"15","author":"Roycik","year":"2009","journal-title":"Curr Pharm Des"},{"key":"R5-9-20210126","first-page":"60","article-title":"Properties and function of heparanase in cancer metastasis and angiogenesis.","volume":"1","author":"Vlodavsky","year":"2001","journal-title":"Haemostasis"},{"key":"R6-9-20210126","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/labinvest.3700084","article-title":"Human heparanase nuclear localization and enzymatic activity.","volume":"84","author":"Schubert","year":"2004","journal-title":"Lab Invest"},{"key":"R7-9-20210126","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/03008200802143281","article-title":". Heparanase: one molecule with multiple functions in cancer progression.","volume":"49","author":"Vlodavsky","year":"2008","journal-title":"Connect Tissue Res"},{"key":"R8-9-20210126","doi-asserted-by":"crossref","first-page":"3890","DOI":"10.1111\/j.1742-4658.2010.07799.x","article-title":"Proteoglycans in health and disease: new concepts for heparanase function in tumor progression and metastasis.","volume":"277","author":"Barash","year":"2010","journal-title":"FEBS J"},{"key":"R9-9-20210126","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1177\/107602960100700210","article-title":". Anticoagulant and antiprotease profiles of a novel natural heparinomimetic mannopentaose phosphate sulfate (PI-88).","volume":"7","author":"Demir","year":"2001","journal-title":"Clin Appl Thromb Hemost"},{"key":"R10-9-20210126","doi-asserted-by":"crossref","first-page":"28010","DOI":"10.1074\/jbc.M110.116384","article-title":". Heparanase 2 interacts with heparan sulfate with high affinity and inhibits heparanase activity.","volume":"285","author":"Levy-Adam","year":"2010","journal-title":"J Biol Chem"},{"key":"R11-9-20210126","first-page":"427","article-title":"Mammalian heparanase: what is the message J Cell Mol M","volume":"11","author":"Vreys","year":"2007","journal-title":"ed"},{"key":"R12-9-20210126","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1097\/MEG.0b013e3282fc2649","article-title":". Heparanase-2, syndecan-1, and extracellular matrix remodeling in colorectal carcinoma.","volume":"20","author":"Peretti","year":"2008","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R13-9-20210126","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1593\/neo.07241","article-title":". Heparanase expression in circulating lymphocytes of breast cancer patients depends on the presence of the primary tumor andor systemic metastasis.","volume":"9","author":"Theodoro","year":"2007","journal-title":"Neoplasia"},{"key":"R14-9-20210126","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1111\/IGC.0b013e3181a834a2","article-title":". Heparanase-2 expression in normal ovarian epithelium and in benign and malignant ovarian tumors.","volume":"19","author":"de Moura","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"R15-9-20210126","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1111\/IGC.0b013e3181ae3f40","article-title":". Quantitative analysis of heparanase gene expression in normal cervical, cervical intraepithelial neoplastic, and cervical carcinoma tissues.","volume":"19","author":"Varchalama","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"R16-9-20210126","first-page":"301","article-title":"Cervical intraepithelial neoplasia.","volume":"8","author":"Richart","year":"1973","journal-title":"Pathol Annu"},{"key":"R17-9-20210126","doi-asserted-by":"crossref","first-page":"R28","DOI":"10.1186\/bcr950","article-title":". Systemic chemotherapy induces microsatellite instability in the peripheral blood mononuclear cells of breast cancer patients.","volume":"7","author":"Fonseca","year":"2005","journal-title":"Breast Cancer Res"},{"key":"R18-9-20210126","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1590\/S1807-59322006000500008","article-title":"Immunohistochemistry quantification by digital computer-assisted method compared to semiquantitative analysis.","volume":"61","author":"Matos","year":"2006","journal-title":"Clinics"},{"key":"R19-9-20210126","first-page":"4655","article-title":". Heparanase expression in primary and metastatic pancreatic cancer.","volume":"61","author":"Koliopanos","year":"2001","journal-title":"Cancer Res"},{"key":"R20-9-20210126","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1172\/JCI4105","article-title":". The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer.","volume":"102","author":"Kleeff","year":"1998","journal-title":"J Clin Invest"},{"key":"R21-9-20210126","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1093\/humrep\/del483","article-title":". Estradiol induces heparanase-1 expression and heparin sulphate proteoglycan degradation in human endometrium.","volume":"22","author":"Xu","year":"2007","journal-title":"Hum Reprod"},{"key":"R22-9-20210126","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1365-2559.2006.02469.x","article-title":"Heparanase expression in nasopharyngeal carcinoma inversely correlates with patient survival.","volume":"49","author":"Bar-Sela","year":"2006","journal-title":"Histopathology"},{"key":"R23-9-20210126","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1593\/neo.06577","article-title":"Heparanase localization and expression by head and neck cancer: correlation with tumor progression and patient survival.","volume":"8","author":"Doweck","year":"2006","journal-title":"Neoplasia"}],"container-title":["Journal of Lower Genital Tract Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00128360-201207000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:39:41Z","timestamp":1786048781000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00128360-201207000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/lgt.0b013e3182422c69","relation":{},"ISSN":["1089-2591"],"issn-type":[{"value":"1089-2591","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}